Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evi Stegmann

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Antibiotics (Basel, Switzerland)|August 1, 2019
Actinomycetes: The Antibiotics ProducersYvonne Mast, Evi Stegmann
International Journal of Medical Microbiology : IJMM|October 3, 2019
SFB 766: 12 years of research on the bacterial cell envelopeEvi Stegmann, Samuel Wagner, Sandra Schwarz
International Journal of Medical Microbiology : IJMM|July 28, 2019
Diversity of peptidoglycan structure-Modifications and their physiological role in resistance in antibiotic producersSandra Unsleber, Wolfgang Wohlleben, Evi Stegmann
Frontiers in Microbiology|August 28, 2020
Editorial: Regulation of Antibiotic Production in ActinomycetesYvonne Mast, Evi Stegmann, Yinhua Lu
Environmental Microbiology|December 5, 2015
Elucidation of the zinc-dependent regulation in Amycolatopsis japonicum enabled the identification of the ethylenediamine-disuccinate ([S,S]-EDDS) genesMarius Spohn, Wolfgang Wohlleben, Evi Stegmann
Current Opinion in Microbiology|October 6, 2010
Glycopeptide biosynthesis in the context of basic cellular functionsEvi Stegmann, Hans-Jörg Frasch, Wolfgang Wohlleben
Methods in Enzymology|April 21, 2009
Chapter 18. Molecular genetic approaches to analyze glycopeptide biosynthesisWolfgang Wohlleben, Evi Stegmann, Roderich D Süssmuth
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
Mining Bacterial Genomes for Secondary Metabolite Gene ClustersMartina Adamek, Marius Spohn, Evi Stegmann, et al.
Microbial Biotechnology|July 30, 2016
Antibiotic drug discoveryWolfgang Wohlleben, Yvonne Mast, Evi Stegmann, et al.
Current Opinion in Biotechnology|August 7, 2022
Beyond vancomycin: recent advances in the modification, reengineering, production and discovery of improved glycopeptide antibiotics to tackle multidrug-resistant bacteriaMathias H Hansen, Evi Stegmann, Max J Cryle
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Antibiotics (Basel, Switzerland)|August 1, 2019
Actinomycetes: The Antibiotics ProducersYvonne Mast, Evi Stegmann
International Journal of Medical Microbiology : IJMM|October 3, 2019
SFB 766: 12 years of research on the bacterial cell envelopeEvi Stegmann, Samuel Wagner, Sandra Schwarz
International Journal of Medical Microbiology : IJMM|July 28, 2019
Diversity of peptidoglycan structure-Modifications and their physiological role in resistance in antibiotic producersSandra Unsleber, Wolfgang Wohlleben, Evi Stegmann
Frontiers in Microbiology|August 28, 2020
Editorial: Regulation of Antibiotic Production in ActinomycetesYvonne Mast, Evi Stegmann, Yinhua Lu
Environmental Microbiology|December 5, 2015
Elucidation of the zinc-dependent regulation in Amycolatopsis japonicum enabled the identification of the ethylenediamine-disuccinate ([S,S]-EDDS) genesMarius Spohn, Wolfgang Wohlleben, Evi Stegmann
Current Opinion in Microbiology|October 6, 2010
Glycopeptide biosynthesis in the context of basic cellular functionsEvi Stegmann, Hans-Jörg Frasch, Wolfgang Wohlleben
Methods in Enzymology|April 21, 2009
Chapter 18. Molecular genetic approaches to analyze glycopeptide biosynthesisWolfgang Wohlleben, Evi Stegmann, Roderich D Süssmuth
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
Mining Bacterial Genomes for Secondary Metabolite Gene ClustersMartina Adamek, Marius Spohn, Evi Stegmann, et al.
Microbial Biotechnology|July 30, 2016
Antibiotic drug discoveryWolfgang Wohlleben, Yvonne Mast, Evi Stegmann, et al.
Current Opinion in Biotechnology|August 7, 2022
Beyond vancomycin: recent advances in the modification, reengineering, production and discovery of improved glycopeptide antibiotics to tackle multidrug-resistant bacteriaMathias H Hansen, Evi Stegmann, Max J Cryle
Pageof 6